BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma (Q34699520)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma
scientific article

    Statements

    BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma (English)
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit